Carter Successfully Pushes FDA to Approve Naloxone for Over the Counter Use
March 30, 2023
March 30, 2023
WASHINGTON, March 30 -- Rep. Buddy Carter, R-Georgia, issued the following news release and letter:
Rep. Earl L. "Buddy" Carter (R-GA) successfully lobbied the Food and Drug Administration (FDA) today to increase access to Emergent Biosolution's life-saving opioid overdose reversal nasal spray, sold under the brand name Narcan, for use without a prescription.
Naloxone nasal spray is a safe, easy to use treatment that is proven "to reduce medical emer . . .
Rep. Earl L. "Buddy" Carter (R-GA) successfully lobbied the Food and Drug Administration (FDA) today to increase access to Emergent Biosolution's life-saving opioid overdose reversal nasal spray, sold under the brand name Narcan, for use without a prescription.
Naloxone nasal spray is a safe, easy to use treatment that is proven "to reduce medical emer . . .